1,1-Cyclohexanediacetic Acid Monoamide (CAM) CAS 99189-60-3 Purity >99.0% (HPLC) Gabapentin Intermediate Factory

Short Description:

1,1-Cyclohexanediacetic Acid Monoamide (CAM)

CAS: 99189-60-3

Purity: >99.0% (HPLC)

Appearance: White Crystalline Powder

Intermediate of Gabapentin (CAS: 60142-96-3)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply Gabapentin Related Intermediates:
Gabapentin CAS 60142-96-3
1,1-Cyclohexanediacetic Acid (CDA) CAS 4355-11-7
Gabapentin-Lactam (CDI) CAS 64744-50-9
1,1-Cyclohexanediacetic Anhydride (CAA) CAS 1010-26-0
3,3-Pentamethylene Glutarimide (CAI) CAS 1130-32-1
1,1-Cyclohexanediacetic Acid Monoamide (CAM) CAS 99189-60-3

Chemical Properties:

Chemical Name	1,1-Cyclohexanediacetic Acid Monoamide
Synonyms	CAM; 1-(Carbamoylmethyl)cyclohexaneacetic Acid; 1-(2-Amino-2-oxoethyl)cyclohexaneacetic Acid
CAS Number	99189-60-3
CAT Number	RF-PI1240
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C10H17NO3
Molecular Weight	199.25
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White Crystalline Powder
Purity / Analysis Method	>99.0% (HPLC)
Melting Point	144.0~148.0℃
Loss on Drying	<0.50%
Residue on Ignition	<0.20%
Imine	<1.0%
Ammonium Salt	<500ppm
CDA	<1.00% (1,1-Cyclohexanediacetic Acid, CAS: 4355-11-7)
Total Impurities	<1.00%
Heavy Metals	<20ppm
Test Standard	Enterprise Standard
Usage	Intermediate of Gabapentin (CAS: 60142-96-3)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

FAQ:

Application:

1,1-Cyclohexanediacetic Acid Monoamide (CAM) (CAS: 99189-60-3) is a key intermediate of Gabapentin (CAS: 60142-96-3). Gabapentin is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain. It is a first-line medication for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central pain. Gabapentin was first approved for use in 1993. It has been available as a generic medication in the United States since 2004. Gabapentin is an Amino acid structurally related to γ-Aminobutyric Acid (GABA), designed to cross the blood brain barrier.